CytomX Therapeutics Inc (CTMX)

1.06 -0.08 (-7.02%) USD  |  NASDAQ  |  Jan 07, 12:29
More

CytomX Therapeutics Research and Development Expense (Quarterly): 21.37M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for CTMX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Spero Therapeutics Inc 26.86M
Castle Biosciences Inc 12.32M
Verastem Inc 24.75M
Arcutis Biotherapeutics Inc 19.50M
NovaBay Pharmaceuticals Inc 0.004M